Purpose: To evaluate positron emission tomography / magnetic resonance imaging (PET/MRI) knee imaging to detect and characterize osseous metabolic abnormalities and correlate PET radiotracer uptake with osseous abnormalities and cartilage degeneration observed on MRI. Materials and Methods: Both knees of 22 subjects with knee pain or injury were scanned at one timepoint, without gadolinium, on a hybrid 3.0T PET-MRI system following injection of 18 F-fluoride or 18 F-fluorodeoxyglucose (FDG). A musculoskeletal radiologist identified volumes of interest (VOIs) around bone abnormalities on MR images and scored bone marrow lesions (BMLs) and osteophytes using a MOAKS scoring system. Cartilage appearance adjacent to bone abnormalities was graded with MRI-modified Outerbridge classifications. On PET standardized uptake values (SUV) maps, VOIs with SUV greater than 5 times the SUV in normal-appearing bone were identified as high-uptake VOI (VOIHigh ). Differences in 18 F-fluoride uptake between bone abnormalities, BML, and osteophyte grades and adjacent cartilage grades on MRI were identified using Mann-Whitney U-tests. Results: SUV max in all subchondral bone lesions (BML, osteophytes, sclerosis) was significantly higher than that of normal-appearing bone on MRI (P < 0.001 for all). Of the 172 high-uptake regions on 18 F-fluoride PET, 63 (37%) corresponded to normal-appearing subchondral bone on MRI. Furthermore, many small grade 1 osteophytes (40 of 82 [49%]), often described as the earliest signs of osteoarthritis (OA), did not show high uptake. Lastly, PET SUV max in subchondral bone adjacent to grade 0 cartilage was significantly lower compared to that of grades 1-2 (P < 0.05) and grades 3-4 cartilage (P < 0.001). Conclusion: PET/MRI can simultaneously assess multiple early metabolic and morphologic markers of knee OA across multiple tissues in the joint. Our findings suggest that PET/MR may detect metabolic abnormalities in subchondral bone, which appear normal on MRI. Level of Evidence: 2 Technical Efficacy: Stage 1
F-fluoride PET, 63 (37%) corresponded to normal-appearing subchondral bone on MRI. Furthermore, many small grade 1 osteophytes (40 of 82 [49%]), often described as the earliest signs of osteoarthritis (OA), did not show high uptake. Lastly, PET SUV max in subchondral bone adjacent to grade 0 cartilage was significantly lower compared to that of grades 1-2 (P < 0.05) and grades 3-4 cartilage (P < 0.001). Conclusion: PET/MRI can simultaneously assess multiple early metabolic and morphologic markers of knee OA across multiple tissues in the joint. Our findings suggest that PET/MR may detect metabolic abnormalities in subchondral bone, which appear normal on MRI. O steoarthritis (OA) is a chronic, degenerative disease of the joint that affects 14 million Americans, causing joint pain, stiffness, and loss of mobility. 1 Despite its widespread prevalence and high societal cost, the pathogenesis of the disease remains poorly understood. Furthermore, there are no disease-modifying treatments, in part because we lack the tools to effectively assess early progression. OA is characterized by degeneration affecting all tissues in the joint, and an optimal imaging tool to study OA must be sensitive both to bone and soft-tissue health. Magnetic resonance imaging (MRI) provides excellent highresolution morphologic information of joint tissue, 2 and great advances have been made to study damage to articular cartilage, meniscus, and ligaments in OA. Quantitative MRI of tissue microstructure in OA, including T 2 or T 1q relaxation times, has shown that early biochemical changes in OA can be detected before tissue loss has occurred, but has primarily focused on soft tissue. [3] [4] [5] In contrast, bone metabolism cannot be directly measured using MRI. Changes in bone metabolism are known to occur with OA, particularly in the subchondral region, 6 but have received limited attention in the literature. Unlike many soft tissues in the joint, subchondral bone is a highly vascularized and metabolically active tissue that undergoes continuous remodeling. 6 Bone remodeling serves to adjust bone architecture to meet changing mechanical loads on the joint, to repair micro-damage in the bone matrix, as well as to respond to trauma or bone pathology. 7, 8 While this subchondral bone remodeling is important to normal joint function, increased bone remodeling has been linked to the progression of OA, particularly in the early stages of the disease. 6, 9 Subchondral bone pathology has also been associated with cartilage loss in OA progression. 10, 11 Inflammatory processes have been cited as a possible mechanism of OA tissue degeneration. In particular, bone marrow lesions (BMLs) have been strongly associated with knee pain 12 and joint space narrowing. 13 However, these lesions are heterogeneous and their multifactorial etiology and pathogenesis are still poorly understood. Positron emission tomography (PET)/MRI systems allow for comprehensive imaging of the whole joint, including soft tissues and bone, which is necessary to study complex disease processes in OA. 14, 15 This presents an opportunity to simultaneously assess the role of metabolic activity in OA with PET markers, and relate them to qualitative MRI metrics of bone pathologies in OA. Additionally, it allows for the assessment of spatial relationships between subchondral bone remodeling and cartilage health. Several commercially available PET radiotracers are promising for studying metabolic processes in OA. 18 Ffluoride is a long-recognized bone-seeking agent that is able to probe bony remodeling. [16] [17] [18] Additionally, fluorodeoxyglucose ( 18 F-FDG) PET is a widely used marker for glucose metabolism and is sensitive to areas of acute phase cellular response (neutrophils or PMNs), such as inflammation. 19 The purpose of our study was to investigate the potential of PET/MR knee imaging to detect and characterize osseous metabolic abnormalities in patients with knee pain or prior injury and correlate degenerative bone and cartilage findings on MRI with subchondral 18 F-fluoride uptake on PET.
Materials and Methods

Study Population
From September 2014 to July 2016, 22 patients with a prior history of knee injury or pain were recruited for the study. Subjects with known high-grade OA, pregnant women, and children were excluded from participating. Prior to participating in the study, all subjects were informed about the nature of the study and provided consent according to the University Institutional Review Board. The study was Health Insurance Portability and Accountability Act (HIPAA)-compliant.
PET-MRI Scanning
Both knees of each subject were scanned on a 3T whole-body time-of-flight PET-MR hybrid system (GE Healthcare, Milwaukee, WI) following injection of 2-5 mCi of 18 F-fluoride and a 45-minute delay to allow for tracer uptake. In addition, three subjects received a second PET/MRI scan on a separate day using injection of 5 22 . MRAC uses an automated anatomic segmentation and assigns tissue-specific linear attenuation coefficients to each segmented tissue. PET data were acquired simultaneously for the entire duration of the MRI scan. The scan time for each knee was 30 minutes for a total scan time of roughly 1 hour.
18 F-Fluoride PET (SUV) and MRI images of a 52-year-old male patient with posttraumatic osteoarthritis showing concordance between a BML (blue arrowhead) and osteophytes (red diamond arrows) on MRI with high 18 F-fluoride uptake on PET. Additionally, a focal region of high uptake on PET (magenta line arrow) did not exhibit bone abnormalities on MRI but was adjacent to a grade 2 cartilage defect (light blue solid arrow).
Image Analysis
A musculoskeletal radiologist with 22 years of experience (G.G.) identified volumes of interest (VOIs) around bone abnormalities on MR images. This included "bone marrow lesions" (BMLs) identified as areas of high T 2 signal in subchondral bone, 23 osteophytes identified as bony protrusions on zTE MR images, and subchondral sclerosis, identified as subchondral bone with low signal intensity on both fat-saturated T 2 -weighted FSE images and Dixon fat images. 23 Additionally, BMLs and osteophytes were scored according to MRI Osteoarthritis Knee Score (MOAKS). 24 For both 18 F-fluoride and 18 F-FDG PET acquisitions, standardized uptake values (SUVs) images were reconstructed from list-mode data onto a 192 3 192 matrix using time-of-flight PET reconstruction. VOIs with SUV greater than 5 times the reference SUV in normal bone (ie, the mean SUV from a region of normal-appearing trabecular bone in the medial femoral condyle) were identified as high-uptake VOI (VOI High ) on PET SUV maps. Furthermore, SUV max from VOI High that did not correspond to any MRI findings were identified. Lastly, cartilage adjacent to identified areas of bone abnormalities and VOIHigh was graded by a radiologist (G.G.) according to an MRImodified Outerbridge classification (Grade 0: normal-appearing cartilage; Grade 1: Signal intensity alterations with no loss of cartilage thickness; Grade 2: Shallow superficial ulceration, fibrillation, or fissuring involving less than 50% of the depth of the articular surface; Grade 3: Deep ulceration, fibrillation, fissuring, or a chondral flap involving 50% depth or more of the articular cartilage without exposure of subchondral bone; Grade 4: Full-thickness chondral wear with exposure of subchondral bone). 25, 26 We tested the hypothesis that maximum SUV (SUV max ) on PET images differed between different bone pathologies (identified on MRI) as well as from normal-appearing bone using the MannWhitney U-test. Similarly, differences in 18 F-fluoride PET uptake related to BML and osteophyte grades identified on MRI using a Mann-Whitney U-test with Bonferroni correction. Lastly, differences in 18 F-fluoride PET uptake for different adjacent cartilage grades determined from MR images using a Mann-Whitney U-test with Bonferroni correction. All statistical analyses were performed using the statistical toolbox for MatLab (MathWorks, Natick, MA) and P-values less than 0.05 were considered statistically significant.
Results
All subjects had subchondral bone and cartilage features of OA as identified on MRI. Twenty-two subjects (mean age 36.8 6 14.8 years, 16 male, 6 female) were included in the study with a mean body mass index (BMI) of 26. (Table 1) . Furthermore, SUV max in BMLs was significantly higher than that of osteophytes and subchondral sclerosis (P < 0.001 for both) (Fig. 3) . SUV max in all subchondral bone lesions (BML, osteophytes, sclerosis) was significantly higher than that of normal-appearing bone on MRI (P < 0.001 for all).
BMLs with higher MOAKS score on MRI showed higher 18 F-fluoride uptake on PET (Fig. 4a) . Mean SUV max of 7.7 6 1.6, 13.2 6 3.5, 25.4 6 8.9 were observed in grade 1, grade 2, and grade 3 BMLs, respectively (Fig. 4a) . Grade 2 and grade 3 BMLs both showed significantly higher SUVmax than grade 1 BMLs (P < 0.001 for both). F-fluoride uptake in areas of subchondral bone abnormalities identified on MRI was significantly greater than that of normal-appearing bone. Differences were also observed between SUV max and adjacent cartilage grade. Mean SUV max increased with cartilage grade from 5.9 6 3.3 in normal-appearing (grade 0) cartilage; to 7.6 6 4.3 in mildly degenerated (grade 1-2) cartilage; to 9.5 6 5.3 in severely degenerated (grade 3-4) cartilage (Fig. 7 ). Significant differences were observed between PET SUV max in subchondral bone adjacent to grade 0 cartilage compared to grade 1-2 (P < 0.05) and grade 3-4 cartilage (P < 0.001) as well as between grade 1-2 and grade 3-4 cartilage (P < 0.05). Additionally, differences were observed between the mean cartilage grade adjacent to BMLs (2.3 6 1.0), osteophytes (1.5 6 1.1), and regions of high uptake with no associated subchondral bone MRI findings (1.1 6 1.1).
Uptake of 18 F-FDG in subchondral BMLs was substantially lower than that of 
Discussion
Hybrid PET-MR systems allow for simultaneous, sensitive, and quantitative assessment of bone, articular cartilage, and other soft tissues and may be an optimal method to study OA. MRI has become the standard for evaluation of soft tissue in joints. This work shows the addition of PET provides an opportunity to concurrently measure changes in the bone metabolic activity. This combination may not only help understand bone pathology in OA but may also provide crucial information linking changes in soft tissue with bone remodeling and inflammation.
PET imaging allows for quantitative assessment of functional changes that occur in OA at the molecular level. While bony pathology has long been thought to play an important role in the development of OA, its etiology, activity, and progression is still poorly understood. This study demonstrated the sensitivity of 18 F-fluoride PET to osteoblastic processes and its potential to quantitatively evaluate subchondral bone remodeling and other metabolic abnormalities in bony pathology in OA.
Findings of abnormalities that only appeared on MRI or as areas of high 18 F-fluoride uptake on PET are of particular interest. Of all VOI High identified on 18 F-fluoride PET, 37% corresponded to normal-appearing subchondral bone marrow on MRI. As molecular changes often precede changes at the tissue level, 18 F-fluoride may serve as a marker of early bone remodeling changes that occurs before structural MRI damage is seen in the joint. This is further supported by the association of 18 F-fluoride PET regions of VOI High with adjacent mild (grades 1-2) cartilage degeneration that was often observed on MRI. Biomarkers that effectively assess early progression of OA are crucial for the development and evaluation of disease modifying Of equal importance, a lack of metabolic activity may indicate that certain lesions play a limited role in OA pathogenesis. While there was frequent colocalization between grade 2 (93%) and grade 3 (100%) osteophytes and MRI abnormalities, more than half of grade 1 osteophytes identified on MRI did not correlate with high 18 F-fluoride uptake. These small osteophytes are thought to be the earliest signs of radiographic OA and PET data suggest their metabolic activity is not elevated. 18 F-fluoride PET provides a quantitative measure to characterize these lesions and study their effect on the progression of OA. Our BMLs have been a topic of increasing interest in OA because they are considered significant sources of pain 12 and are linked to the radiographic severity of OA 27 and increased rate of OA progression. 13 Despite a putative link between BMLs and symptoms of OA, current identification of BMLs as areas of high signal in bone on fat suppressed T 2 -weighted images is not quantitative and often a late finding. As such, the importance of individual lesions as identified on MRI on the progression of OA is poorly understood.
18
F-fluoride PET offers the ability to quantify bone remodeling and osteoblast metabolic activity in BMLs. Our 18 F-fluoride findings suggest that BMLs identified on MRI are significantly more metabolically active for bone remodeling than other bone pathology (eg, osteophytes and 18 F-FDG (top) and 18 F-fluoride (bottom) PET SUV maps and corresponding MR images for a 23-male year-old subject. Increased 18 F-FDG uptake (cyan arrow) is observed around the graft that may be indicative of graft impingement or revascularization. Additionally, increased 18 F-fluoride uptake (magenta arrow) indicative of bone remodeling is seen adjacent to the graft. 18 Ffluoride and 18 F-FDG provide complementary information regarding subchondral bone remodeling and soft-tissue inflammation and could potentially be utilized together to study OA degeneration in the entire joint. sclerosis) as well as normal-appearing areas on MRI. BMLs were also associated with more severe degeneration of the adjacent cartilage compared with other bone pathologies. An association between BMLs and cartilage damage is in agreement with prior literature that showed BMLs are linked with loss and degeneration of the overlying cartilage. 10, 28 Another important point of discussion is the role of inflammation on BMLs in OA. In addition to degenerative arthropathies, BMLs are also associated with rheumatoid arthritis, bone trauma, as well as ischemic and neoplastic disorders. 29 While previous work has demonstrated that BMLs in OA has less of an inflammatory component than in rheumatoid arthritis, 30 there are varying theories about the involvement of inflammation in OA. Our early results show considerable 18 F-fluoride and minimal 18 F-FDG uptake in BMLs relative to normal-appearing bone, suggesting that bone remodeling processes play a larger role in these lesions compared with inflammatory processes. However, a larger study is necessary to determine uptake of 18 F-FDG in these lesions. This finding agrees with prior work that showed that BMLs may not respond to antiinflammatory treatments in knee OA. 31 One of the biggest benefits of hybrid PET-MR imaging of OA is the ability to simultaneously evaluate molecular and morphologic spatial relationships across multiple tissues. In this study, we evaluated the relationship between metabolic bony activity in subchondral bone pathology and cartilage morphology. A trend was seen between increased 18 Ffluoride PET uptake and increasing structural degeneration in the adjacent cartilage as semiquantitatively assessed using a modified Outerbridge scoring system. This finding suggests that degenerative changes and processes in bone and cartilage are linked.
F-fluoride PET, in combination with early MRI metrics of cartilage biochemistry, 32 may provide an optimal method to study relationships between adjacent tissue degeneration in early OA. Other PET tracers, such as 18 F-FDG, may provide complementary information about soft tissue inflammation, and could be utilized in combination to study OA degeneration in the entire joint. While 18 F-fluoride has been extensively used to image bone metastases, it has only more recently been applied to degenerative joint disease. [33] [34] [35] Kobayashi et al showed that increasing severity of hip pain correlated with increasing SUV max . In addition, they showed that SUV max was significantly higher in hip joints with an abnormal finding in bone on MRI. 33 A separate study showed subjects with patellofemoral pain exhibited elevated 18 F-fluoride uptake indicative of increased bone metabolic activity at the patellofemoral joint, but did not always correspond to structural damage in the bone or cartilage on MRI. 34 However, these studies performed 18 F-fluoride PET and MR in separate scan sessions and did not evaluate individual bone abnormalities. Additionally, spatial relationships between subchondral bone metabolism and cartilage changes were not assessed.
Simultaneous acquisition of PET and MRI data allows for considerable reduction in scan time while obtaining registered images. Furthermore, since PET data are acquired for the duration of the MRI protocol, this permits a reduction in the dose of radiotracer needed as compared to PET-CT. In this study, because PET data were acquired for the duration of the 30-minute MRI protocol, the injected dose of 18 F-Fluoride was decreased from a standard clinical dose of 5.0 mCi to 2.0 mCi while maintaining a high signal-tonoise ratio in PET SUV maps. For an adult, this is an estimated effective dose of 1.4 mSv. As MRI is nonionizing, this protocol allows for simultaneous acquisition of functional and high-resolution anatomical data with a minimal effective dose to the subject. It is also important to point out several limitations to this study. This study used a cross-sectional analysis of subjects with knee pain and injuries. BMLs are heterogeneous, with a diverse etiology, and their size and features are known to change over time. We believe the BMLs in these subjects are the result of degenerative osteoarthropathy, but serial tracking of these lesions is needed to better understand the role of bone remodeling and inflammation in these pathologies. Additionally, while an association between 18 Ffluoride uptake in subchondral bone and cartilage damage on MRI was observed, longitudinal studies are needed to determine the chronological order of these changes.
For imaging techniques, it should also be noted that radiographs are the standard imaging method used to detect osteophytes and subchondral sclerosis, as bone is ordinarily invisible on conventional MRI due to the extremely short life-time (T 2 ) of its protons. However, zTE MRI allows for visualization of short T 2 species such as bone, and our radiologist has over 20 years of experience identifying these lesions on MRI. Lastly, PET photon attenuation due to the flexible coil array used for MRI was not accounted for in calculation of PET SUV maps. This likely led to an underestimation of calculated SUV values, although we expect the tracer distributions to be preserved with and without this coil. 36 No histopathology was acquired in this study; thus, we could not confirm that high PET uptake correlated to bone pathology. Instead, we have described these as abnormalities in bone metabolism. Additionally, an asymptomatic control population with no history of knee problems has not yet been studied. While a lack of abnormal PET or MRI findings was observed in the contralateral knee of several subjects with unilateral knee injury, more studies are needed to determine the range of PET radiotracer uptake in normal controls. Furthermore, the patient population used in this study was small and heterogeneous including a range of ages, pain, and included postsurgical patients. As a feasibility study, we felt it appropriate to study a broad range of subjects. As such, the findings of this study are observations, which highlight the potential of PET/MRI to simultaneously study multiple functional and morphologic factors in the knee. More targeted studies in homogeneous patient cohorts are needed to make conclusions about the use of 18 F-fluoride or 18 F-FDG as markers of OA pathogenesis.
This work presents a novel technique to simultaneously assess early metabolic and structural markers of knee OA across multiple tissues in the joint. 18 F-fluoride PET/MR may detect knee abnormalities unseen on MRI alone and is a promising tool for detection of early metabolic changes in OA. Further, higher 18 F-fluoride uptake corresponds to worse degeneration in the adjacent cartilage, suggesting a spatial relationship between bone remodeling and cartilage health. Use of additional tracers such as 18 F-FDG PET can provide complementary information about inflammatory processes occurring in soft tissues. PET/MRI thus can simultaneously assess multiple early metabolic and biochemical markers of knee OA progression across all tissues in the joint. This information may provide new insights into OA pathogenesis and lead to new treatment targets to arrest the onset and progression of OA.
